HUANG Xiangning,WANG Yifei,YU Yunfeng,et al.Animal Modeling of Diabetic Nephropathy:[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(13):188-196.
HUANG Xiangning,WANG Yifei,YU Yunfeng,et al.Animal Modeling of Diabetic Nephropathy:[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(13):188-196. DOI: 10.13422/j.cnki.syfjx.20230517.
Animal Modeling of Diabetic Nephropathy:A Study Based on Literature
To summarize the modeling elements, evaluation indicators, characteristics, and drawbacks of the animal models of diabetic nephropathy, and thus provide guidance for the standardized modeling and rational application of these models.
Method
2
The articles about the animal experiments of diabetic nephropathy published in the last decade were retrieved from China National Knowledge Infrastructure, Wanfang Data, and PubMed. The data of animal species, sex, modeling techniques, modeling criteria, and evaluation indicators were analyzed in Excel.
Result
2
A total of 287 publications were included in this study. Male SD rats were mainly used for the modeling of diabetic nephropathy. The animal models of type 1 diabetes were mainly established by intraperitoneal injection of streptozotocin (STZ) at 60-69 mg·kg
-1
once or 50 mg·kg
-1
for 5 continuous days, and those of type 2 diabetes by intraperitoneal injection of STZ at 30-39 mg·kg
-1
once or 30 mg·kg
-1
for 2 continuous days combined with 4 weeks of high-fat and high-sugar diet. Blood glucose and 24-hour urine protein were mainly used to determine whether the modeling was successful. The evaluation indicators of the animal models mainly included basic indicators, glucose and lipid metabolism indicators, and renal function indicators.
Conclusion
2
Animal models are commonly used in the research on diabetic nephropathy, while there is no unified standards for the preparation or evaluation of the animal models. Moreover, Chinese medicine is rarely considered in the modeling. Through literature review and data analysis, this paper summarizes the modeling elements and standards, key evaluation indicators, characteristics, and shortcomings, aiming to build the animal models of diabetic nephropathy with a high success rate and with the characteristics in line with the clinical pathogenesis and syndromes.
DENG Y, LI N, WU Y, et al.Global,regional,and national burden of diabetes-related chronic kidney disease from 1990 to 2019[J].Front Endocrinol (Lausanne),2021,12:672350.
窦如海.实验动物与动物实验技术[M].济南:山东科学技术出版社,2006.
GIRALT-LÓPEZ A,MOLINA-VAN DEN BOSCH M,VERGARA A,et al.Revisiting experimental models of diabetic nephropathy[J].Int J Mol Sci,2020,doi:10.3390/ijms21103587http://dx.doi.org/10.3390/ijms21103587.
GU W,YANG L,WANG X,et al.Pterostilbene,a resveratrol derivative,improves ectopic lipid deposition in the kidneys of mice induced by a high-fat diet[J].Kidney Blood Press Res,2022,47(8):514-522.
GIANDALIA A,GIUFFRIDA A E,GEMBILLO G,et al. Gender differences in diabetic kidney disease: Focus on hormonal, genetic and clinical factors[J].Int J Mol Sci,2021,22(11):5808
SPIRES D R,PALYGIN O,LEVCHENKO V,et al.Sexual dimorphism in the progression of type 2 diabetic kidney disease in T2DN rats[J].Physiol Genomics,2021,53(6):223-234.
SEMBACH F E,FINK L N,JOHANSEN T,et al.Impact of sex on diabetic nephropathy and the renal transcriptome in UNx db/db C57BLKS mice[J].Physiol Rep,2019,7(24):e14333.
AL-AWAR A,KUPAI K,VESZELKA M,et al.Experimental diabetes mellitus in different animal models[J].J Diabetes Res,2016,2016:9051426.
GURLEY S B,MACH C L,STEGBAUER J,et al.Influence of genetic background on albuminuria and kidney injury in Ins2(+/C96Y) (Akita) mice[J].Am J Physiol Renal Physiol,2010,298(3):F788-795.
SOLER M J,RIERA M,BATLLE D.New experimental models of diabetic nephropathy in mice models of type 2 diabetes: efforts to replicate human nephropathy[J].Exp Diabetes Res,2012,2012:616313.
BIVONA B J,PARK S,HARRISON-BERNARD L M.Glomerular filtration rate determinations in conscious type II diabetic mice[J].Am J Physiol Renal Physiol,2011,300(3):F618-625.
BROUWERS B,PRUNIAU V,CAUWELIER E,et al.Phlorizin pretreatment reduces acute renal toxicity in a mouse model for diabetic nephropathy[J].J Biol Chem,2013,288(38):27200-27207.
TAY Y C,WANG Y,KAIRAITIS L,et al.Can murine diabetic nephropathy be separated from superimposed acute renal failure?[J].Kidney Int,2005,68(1):391-398.
NOSHAHR Z S,SALMANI H,KHAJAVI RAD A,et al.Animal models of diabetes-associated renal injury[J].J Diabetes Res,2020,2020:9416419.
MOJANI M S,SARMADI V H,VELLASAMY S,et al.Evaluation of metabolic and immunological changes in streptozotocin-nicotinamide induced diabetic rats[J].Cell Immunol,2014,289(1/2):145-149.
GLASTRAS S J,CHEN H,TEH R,et al.Mouse models of diabetes,obesity and related kidney disease[J].PLoS One,2016,11(8):e0162131.
UIL M,SCANTLEBERY A,BUTTER L M,et al.Author correction:Combining streptozotocin and unilateral nephrectomy is an effective method for inducing experimental diabetic nephropathy in the 'resistant' C57Bl/6J mouse strain[J].Sci Rep,2019,9(1):3425.
PARK K M,HUSSEIN K H,NAM H S,et al.A novel mouse model of diabetes mellitus using unilateral nephrectomy[J].Lab Anim,2016,50(2):88-93.
MALLIPATTU S K,GALLAGHER E J,LEROITH D,et al.Diabetic nephropathy in a nonobese mouse model of type 2 diabetes mellitus[J].Am J Physiol Renal Physiol,2014,306(9):F1008-1017.
KATSUDA Y,KEMMOCHI Y,MAKI M,et al.Effects of unilateral nephrectomy on renal function in male spontaneously diabetic torii fatty rats:A novel obese type 2 diabetic model[J].J Diabetes Res,2014,2014:363126.
BETZ B,CONWAY B R.An update on the use of animal models in diabetic nephropathy research[J].Curr Diab Rep,2016,16(2):18.
RUTLEDGE J C,NG K F,AUNG H H,et al.Role of triglyceride-rich lipoproteins in diabetic nephropathy[J].Nat Rev Nephrol,2010,6(6):361-370.
THIPSAWAT S.Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus:A review of the literature[J].Diab Vasc Dis Res,2021,18(6):14791641211058856.
QI C,MAO X,ZHANG Z,et al.Classification and differential diagnosis of diabetic nephropathy[J].J Diabetes Res,2017,2017:8637138.
TANG G,LI S,ZHANG C,et al.Clinical efficacies,underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management[J].Acta Pharm Sin B,2021,11(9):2749-2767.